MedPath

iver protective effect of Tinospora Cordifolia plant (Guduchi) in TB patients

Phase 2
Conditions
Health Condition 1: A150- Tuberculosis of lung
Registration Number
CTRI/2024/07/071071
Lead Sponsor
Dayananda Sagar University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Age: 18-75 years

TB patients on standard ATT regimen (INH & Rifampicin)

Exclusion Criteria

Drug resistant TB

ALT, & AST more than 5x ULN at baseline

Bilirubin more than 2x ULN at baseline

Pregnancy and Lactation

Concomitant use of glibenclamide and immunosuppressants

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Patients exhibiting improvements in their clinical symptoms: levels of bilirubin, ALT, AST, and HMGB1, GGT and Glutathione and other clinical indicators of liver function will be within the normal rangeTimepoint: 2 months
Secondary Outcome Measures
NameTimeMethod
Altered levels of levels of bilirubin, ALT, AST, and HMGB1, GGT and Glutathione and other clinical indicators of liver functionTimepoint: 2 months
© Copyright 2025. All Rights Reserved by MedPath